Village Farms International (VFF) Q3 2026 earnings review
Village Farms exports hold their record, but cannabis margins drop
Village Farms kept European medical cannabis exports at a record high, while weaker Canadian wholesale prices cut into profit margins. Total sales held near $67 million as a 75% jump in overseas shipments offset drops across North American and Dutch channels. Chief executive Michael DeGiglio blamed the 7-point cannabis gross margin decline on cheap Canadian wholesale trim, while slower expansion spending let cash climb to $80 million.
| International export sales | $20.8M +75% from a year ago, matching Q2's record |
|---|---|
| Cannabis gross margin | 48% 55% a year ago and 51% last quarter |
| Uncollected customer bills | $41.6M +80% from year-end ($32.4M last quarter) |
| Total cash and restricted cash | $79.9M up from $72.9M last quarter as expansion spending ended |
⚖️ Verdict: ⚪ Neutral
The standing story is unchanged because steady European export demand was balanced by lower margins and another delay in new European markets. Exports proved they could hold $21 million for a second quarter, and cash generation returned as greenhouse construction wound down. One caution: unpaid customer bills jumped to $42 million even though export sales did not grow from last quarter, and Dutch sales fell 15% during planting.
The question now is whether the cannabis gross margin drop to 48% was a one-quarter dip from Canadian wholesale trim or the start of European price pressure. Management says new Canadian wholesale contracts will lift margins in the fourth quarter, whereas bears worry competing supply in Germany is squeezing export profits. Fourth-quarter cannabis gross margin and Dutch harvest sales will settle it.
🐂 Bull Case
International Exports Held Their Record Level
Village Farms grows medical cannabis in British Columbia at a greenhouse holding European Union Good Manufacturing Practice (EU-GMP) certification, the quality standard required for European medical imports. While bears worry new supply in Germany will force prices down, chief executive Michael DeGiglio said "International export sales grew 75% year-over-year, in line with last quarter’s record, and more importantly with resilient pricing relative to non-GMP compliant areas of the supply chain".
Export revenue reached $20.8 million, matching last quarter's $20.9 million and providing 37.8% of cannabis sales by our math. That steady demand kept cannabis revenue up 2.8% at a record $55.0 million even though every North American and Dutch sales channel shrank from a year ago.
What to watch: the average selling price and bulk flower share in the third-quarter filing. A steady price per gram would show German medical buyers still pay a premium for certified flower.
Greenhouse Spending Wound Down and Cash Rose
Village Farms spent the first half of 2026 paying for two major greenhouse expansions in Canada and the Netherlands, which left first-half operating cash flow negative. Management promised that cash would grow in the second half once construction bills ended.
In the third quarter, the grower generated $9.5 million of operating cash flow because expansion capital spending was nearly finished. Total cash and restricted cash rose to $79.9 million from $72.9 million in June, leaving $41.2 million of cash after subtracting $38.7 million of total debt by our math.
What to watch: fourth-quarter operating cash flow and capital spending in the full-year report. Another cash build without share sales would confirm the new greenhouses can fund themselves.
🐻 Bear Case
Wholesale Trim and Higher Costs Cut Margin
Even with high-margin European exports near 38% of cannabis revenue, cannabis gross margin dropped from 55.3% a year ago and 51.0% last quarter to 47.5%. DeGiglio blamed "a softer spot trim market in the Canadian wholesale sales channel", where the grower sells plant trimmings to other producers, and predicted a fourth-quarter rebound from "commencement of new supply agreements with considerably stronger contracted pricing".
- Canadian non-branded wholesale sales: $3.3 million, down 55.1% from $7.3 million a year ago
- Cannabis cost of sales: 52.5% of cannabis revenue, up 7.8 percentage points from a year ago by our math
- Cannabis selling and administrative expenses: 27.6% of cannabis revenue, up 4.6 percentage points by our math
- Cannabis profit before interest, taxes, depreciation and one-offs: $14.7 million, down 27.1% from a year ago
What to watch: fourth-quarter Canadian non-branded revenue and cannabis gross margin. A rebound above 50% would prove the drop came from temporary wholesale trim prices rather than European price pressure.
Netherlands Sales Slipped as Europe Entry Delayed
Village Farms counts on its second Dutch facility in Groningen and new European countries to drive its next wave of growth. DeGiglio said "our Phase II Netherlands facility is now fully planted", while also noting the Delta 2 greenhouse will join "our entrance into multiple new European jurisdictions" next year.
Both timelines have slipped behind management's earlier schedules. Dutch branded revenue fell 20.9% from a year ago and 15.2% from last quarter to $2.8 million because harvest volumes were "temporarily reduced by propagation activities" to plant the new rooms, and entering new European markets moved from the second half of 2026 into 2027.
What to watch: fourth-quarter Netherlands branded revenue. A move above the $3.6 million quarterly peak from a year ago would show the newly planted Groningen rooms are finally selling into Dutch coffee shops.
Uncollected Customer Bills Jumped 80% This Year
Selling medical cannabis to overseas distributors takes longer to collect in cash than selling to Canadian provincial boards. Trade receivables — bills that customers have not yet paid — climbed another 28.4% from June to $41.6 million, up 79.7% from $23.2 million at the end of December by our math.
That $18.5 million nine-month build in unpaid bills soaked up most of the company's earnings, leaving nine-month cannabis operating cash flow at $4.4 million against $42.7 million a year ago. Export sales stayed flat from the second quarter at $20.8 million, yet unpaid customer bills rose by $9.2 million in three months.
What to watch: the receivables aging schedule and allowance for doubtful accounts in the quarterly filing. Rising overdue balances would mean export growth is being financed by extending looser credit to European buyers.
Risks this quarter didn't answer
Four standing risks in the business either worsened slightly or received no new numbers in the release.
- U.S. hemp ban: U.S. cannabis sales fell 16.2% from a year ago to $2.8 million, and the December 11, 2026 federal hemp ban decision will determine whether its full-spectrum CBD products remain legal.
- Canadian excise taxes: Canadian branded sales fell 5.8% to $25.3 million, and excise taxes took 39.4% of gross branded sales by our math; future quarterly tables will show if domestic volume keeps shrinking.
- Deal-making and dilution: Village Farms moved former finance chief Stephen Ruffini to Head of Mergers & Acquisitions after issuing shares in June; any acquisition announcement will test capital discipline.
- German buyer concentration: the release does not name major German distributors, so the quarterly filing's customer concentration note is the next check.
👓 Other Themes
Texas Mobilization and Delta 1 Conversion Option
Village Farms began "mobilizing efforts to operationalize its standalone 30-acre (1.3 million sq. ft.) greenhouse in Monahans, Texas for cannabis production" and notified 37.9%-owned produce partner Verdexa Holdings to keep "optionality to convert 16 acres (700,000 sq. ft.) of the Delta 1 facility to cannabis production during 2027". Management has not finalized Delta 1 conversion plans or disclosed budgets for either site.
💲 Other KPIs
Basic share count rose 8.2% from 113.0 million a year ago by our math, and up from 116.2 million in the second quarter. The increase follows the June sale of 7.5 million shares at $2.00 each, which came right after the company finished buying back shares at higher prices.
Inventories held steady against $46.7 million in the second quarter, up 11.8% from $41.5 million at the end of 2025 by our math. Stopping the inventory build helped third-quarter operating cash flow recover, even as unpaid customer bills continued to climb.
Sales from residual produce marketing and landfill clean energy fell 10.1% from a year ago by our math, as produce sales dropped 12.2% to $11.3 million. However, lower produce costs lifted the segment's profit before interest, taxes, depreciation and one-offs by 23.5% to $3.4 million.
🔮 Guidance
Unchanged. Construction at the Delta 2 greenhouse in British Columbia remains on schedule to finish in the first quarter of 2027 and reach full 40-tonne annual output by mid-2027, lifting total Delta campus capacity by 33% to 160 metric tonnes. The release did not repeat the earlier 15-tonne harvest target for the second half of 2026.
Unchanged. The Groningen facility is now fully planted and management expects it to contribute to stronger sales in the fourth quarter before reaching maximum annualized capacity in early 2027. The timeline held after slipping in each of the previous three quarters from an original late-2025 target.
New. Management expects Canadian wholesale trim volumes and prices to begin recovering in the fourth quarter after hitting a trough in the third quarter, citing October order visibility and new supply contracts at higher prices.
❓ Key Questions
Why did receivables jump $9M when exports were flat?
Trade receivables climbed from $32.4 million in June to $41.6 million in September even though international export sales were unchanged at $20.8 million. Have European distributors asked for longer payment terms, or are any accounts past due?
Did the 15-tonne Delta 2 harvest target for 2026 hold?
In the first and second quarters, management projected 15 metric tonnes of incremental flower from the Delta 2 expansion in 2026, but the third-quarter release omitted that figure. How many tonnes did Delta 2 add in Q3 and what is expected in Q4?
Why did entering new European markets slip to 2027?
Management previously expected to enter new European medical cannabis countries in the first half of 2026, then the second half of 2026, and now says next year. Which regulatory approvals or distributor agreements caused the delay?
What will the Texas and Delta 1 conversions cost?
Village Farms is mobilizing its 30-acre Monahans, Texas greenhouse and kept an option to convert 16 acres of Delta 1 in British Columbia during 2027. What capital spending and licensing milestones are required before planting begins at either site?